Finally, five genes, downregulated in MA-K to MA-L, SSPN, CD52, VPREB3, CCDC82, and ANKRD37, were significantly correlated with poor prognosis of human DLBCL (Figure 4B). This evidence concerns the gene CD52 and diffuse large B-cell lymphoma.